Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of different induction courses in children and adolescents
with newly diagnosed acute myeloid leukemia. In the first course patients are randomised to
receive either standard anthracycline therapy with mitoxantrone or experimental DaunoXome. In
the second course patients are randomised between standard treatment with ADxE (cytarabine,
DaunoXome, etoposide) or experimental therapy with FLADx (fludarabine, cytarabine,
DaunoXome).